NEW YORK (GenomeWeb) – Ag-bio firm DuPont Pioneer announced today that it has acquired an exclusive license to guided Cas9 genome-editing technology from Vilnius University for all commercial uses, including agricultural ones.

Under the deal, DuPont Pioneer and the university will also collaborate on the technology's development. Financial terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.